We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Steroid Medications Ineffective for Pediatric Respiratory Infections

By HospiMedica staff writers
Posted on 08 Aug 2007
A new study has found that steroid treatment did not prevent hospitalization or improve respiratory symptoms for bronchiolitis, a common and potentially serious viral lower respiratory infection and the most common cause of infant hospitalization.

Researchers of the of the Morgan Stanley Children's Hospital of New York-Presbyterian and Columbia University Medical Center (MSCHONY; NY, NY, USA) compared hospitalization rates for 600 children between the ages of two months and 12 months who visited emergency rooms with moderate-to-severe bronchiolitis. More...
Patients were treated with either a dose of dexamethasone (a glucocorticoid form of steroid medication) or a placebo and evaluated after one hour, and again at four hours. The hospital admission rate for both groups was identical at nearly 40%.

The researchers reported that both groups improved during treatment, but the placebo group did as well as the group treated with active medication. The three-year study was conducted in the emergency departments at 20 hospitals across the United States.
The study was published in the July 26, 2007, edition of the New England Journal of Medicine (NEJM).

"Our study shows that treating bronchiolitis with steroids doesn't work. We hope this study will resolve some of the uncertainty for physicians and families, as we move forward in developing better means of preventing and treating the infection,” said lead author Dr. Joan Bregstein, from MSCHONY, and an assistant clinical professor of pediatrics at Columbia University College of Physicians and Surgeons (New York, NY, USA).

Bronchiolitis is an inflammation of the membranes lining the bronchioles. The majority of children hospitalized for bronchiolitis are under six months old, and most recover from it in eight to 15 days. Although many children with bronchiolitis have mild infections and most do not need hospitalization, children born prematurely or who suffer from heart and lung disease are most at risk for complications.


Related Links:
Morgan Stanley Children's Hospital of New York

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.